IndiaMart
FIEO
Cilostazol is an antiplatelet and vasodilator drug primarily used to treat intermittent claudication in patients with peripheral vascular disease. BLUEPILL EXPRESS supplies high-purity Cilostazol API with global regulatory compliance.
Cilostazol is a phosphodiesterase III (PDE3) inhibitor used to improve blood flow by preventing platelet aggregation and dilating blood vessels. It is primarily indicated for patients suffering from intermittent claudication—a condition caused by reduced blood circulation in the limbs, often due to peripheral artery disease (PAD).
Cilostazol enhances walking distance and reduces pain by increasing cAMP levels in platelets and blood vessels, leading to vasodilation and inhibition of platelet aggregation. It is also used in some cases to prevent stroke and treat coronary artery diseases under clinical guidance.
BLUEPILL EXPRESS provides high-quality Cilostazol API, manufactured under WHO-GMP, ISO, and pharmacopeial (USP/BP/EP) standards. Our API is suitable for the development of oral solid dosage forms like tablets and capsules.
Treatment of intermittent claudication
Peripheral artery disease (PAD)
Adjunct therapy in preventing thromboembolic disorders
Stroke prevention (off-label in some regions)
Purity compliant with pharmacopeial standards
High solubility and stability for easy formulation
Available in bulk for formulation use
Full documentation: COA, MSDS, stability data
Why Choose BLUEPILL EXPRESS?
- Certified global exporter of APIs and formulations
- WHOGMP & ISO-certified production facilities
- Export-ready APIs for regulated markets in the USA, UK, EU, Latin America, Asia, and Africa
- Fast delivery with secure international logistics
- Competitive pricing and responsive customer support
